Aayushi Pratap, Contributor

Author's posts

Under 30 Alum Mammoth Biosciences To Develop Diagnostics For Department Of Defense

Mammoth Biosciences gets funding to develop Crispr based tests to detect biological threats. Company’s CEO, Trevor Martin, says his goal is to develop an easy-to-use and a cost effective test which could be easily accessible.

The Covid-19 Pandemic Is Taking A Toll On The International Tuberculosis Response, New Survey Finds

Testing is down and resources are being diverted, which could lead to increased spread of tuberculosis, according to reports from health advocacy groups.

International Expert Panel Releases New Guidelines On Crispr Genome Editing Tools

Bioethicists said there needs to be more clarity about possible consequences for scientists who may not adhere to guidelines and regulations

No Major Benefits Of Plasma Therapy For Covid-19, New Study From India Finds

A randomized control trial conducted by India’s government found plasma therapy did not reduce death rates and doesn’t stop the progression of the disease.

As Trump Backs Convalescent Plasma, India Wrestles With Its Path Forward

Indian government conducts a clinical trial to understand benefits of convalescent plasma therapy

Scamsters Using Twitter And Instagram To Market Fraudulent Covid-19 Drugs And Diagnostic Kits, Study Finds

Online fraudsters sell illegal Covid-19 medicines and remedies, a major risk to public health.

Treating HIV And Tuberculosis Simultaneously Could Greatly Boost Patient Survival

Tuberculosis (TB), an airborne disease, is is the leading cause of death in HIV patients. A new study calls for better collaboration of HIV and TB treatments for patients coinfected.

Movie Theaters Reopen, But Is It Safe?

Experts say steps such as social distancing, wearing masks are key but concessions could increase risk

Fauci: Covid-19 Vaccines Unlikely To Be Mandatory

The Trump administration is predicting a Covid-19 vaccine could be available in 2021, but Dr. Anthony Fauci said the government can’t force people to take it.